News

Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump
Novo Holdings, the controlling shareholder of Ozempic-maker Novo Nordisk (NVO), nearly doubled its annual income and ...
Fierce Pharma4d
Novo Nordisk plugs more than $1B into upgrade of Brazilian manufacturing operations for injectable drugs, including GLP-1s
While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...